A detailed history of Propel Bio Management, LLC transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Propel Bio Management, LLC holds 624,022 shares of ABEO stock, worth $3.67 Million. This represents 2.29% of its overall portfolio holdings.

Number of Shares
624,022
Previous 1,248,044 50.0%
Holding current value
$3.67 Million
Previous $5.29 Billion 25.47%
% of portfolio
2.29%
Previous 3.43%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$4.12 - $6.32 $2.57 Million - $3.94 Million
-624,022 Reduced 50.0%
624,022 $3.94 Billion
Q2 2024

Aug 12, 2024

BUY
$3.17 - $8.05 $3.96 Million - $10 Million
1,248,044 New
1,248,044 $5.29 Billion

Others Institutions Holding ABEO

About ABEONA THERAPEUTICS INC.


  • Ticker ABEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,950,380
  • Market Cap $35M
  • Description
  • Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...
More about ABEO
Track This Portfolio

Track Propel Bio Management, LLC Portfolio

Follow Propel Bio Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Propel Bio Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Propel Bio Management, LLC with notifications on news.